Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers

被引:0
|
作者
Carlyle, Molly [1 ,2 ]
de Wit, Harriet [3 ]
Leknes, Siri [1 ,4 ]
机构
[1] Univ Oslo, Dept Psychol, N-0317 Oslo, Norway
[2] Univ Queensland, Dept Psychol, St Lucia, QLD, Australia
[3] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL USA
[4] Oslo Univ Hosp, Dept Diag Phys, Oslo, Norway
基金
欧洲研究理事会;
关键词
Adversity; trauma; childhood; reward; amphetamine; methamphetamine; buprenorphine; opioid; subjective; RECEPTOR AVAILABILITY; FAMILY-HISTORY; RESPONSES; DEPRIVATION; TRAUMA; METHYLPHENIDATE; QUESTIONNAIRE; BUPRENORPHINE; VULNERABILITY; ALCOHOLISM;
D O I
10.1177/02698811241268892
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Aims: Early-life adversities are known to alter drug reward processing in rodents. Despite the well-known link between early adversity and the risk of substance use disorder, few studies have measured how childhood adversity affects human drug reward. Here, we assessed the relationship between historical childhood adversities and responses to single doses of methamphetamine, d-amphetamine or buprenorphine in healthy participants.Methods: Using a secondary analysis approach, we assessed the impact of childhood adversity on drug effects from three randomised, placebo-controlled studies in which healthy volunteers received methamphetamine (20 mg oral; n = 35), d-amphetamine (20 mg oral; n = 54) or buprenorphine (0.2 mg sublingual; n = 35). Ratings of feeling effect, liking, disliking, feeling high and wanting more of the drug were collected 15-210 min post-administration, and heart rate changes were analysed using random-intercept mixed-effect models. The area under the curve from these and previous studies was calculated to visualise the relationship between childhood adversity severity and drug effects.Results: Greater childhood adversity was associated with reduced feel effects (significant three-way interactions b = -0.07, 95% CI [-0.12, -0.02], p = 0.009), like effects (b = -0.07, 95% CI [-0.13, -0.00], p = 0.038) and feel high (b = -0.06, 95% CI [-0.10, -0.01], p = 0.020) towards the stimulant drugs 90-180 min post-administration.Conclusions: Childhood adversity was not significantly associated with other subjective or heart rate responses to the drugs. Overall, participants with more childhood adversities reported dampened subjective responses to stimulant drugs, but not to buprenorphine. Future studies should examine the generalisability of these relationships, to identify the mechanisms underlying the link between childhood adversity and drug responsiveness.
引用
收藏
页码:986 / 997
页数:12
相关论文
共 50 条
  • [41] Comparative CNS tolerability of new antiepileptic drugs: An evaluation of data from placebo-controlled studies
    Zaccara, G.
    Balestrieri, F.
    Burchini, G.
    Messori, A.
    EPILEPSIA, 2006, 47 : 129 - 129
  • [42] Residual effects of middle of the night dosing: a placebo-controlled crossover study of indiplon-IR, zolpidem, and zopiclone in healthy volunteers
    Garber, M
    Burke, J
    Farber, R
    Jochelson, P
    Campbell, B
    SLEEP, 2004, 27 : 260 - 260
  • [43] Effects of intensity of electroacupuncture upon experimental pain in healthy human volunteers: A randomized, double-blind, placebo-controlled study
    Barlas, Panos
    Ting, Sharlene L. H.
    Chesterton, Linda S.
    Jones, Peter W.
    Sim, Julius
    PAIN, 2006, 122 (1-2) : 81 - 89
  • [44] A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers
    Hindmarch, Ian
    Legangneux, Eric
    Stanley, Neil
    Emegbo, Steve
    Dawson, Jean
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (05) : 538 - 545
  • [45] A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO COMPARE THE AUTONOMIC EFFECTS OF FLUVOXAMINE WITH THOSE OF AMITRIPTYLINE AND DOXEPIN IN HEALTHY-VOLUNTEERS
    WILSON, WH
    HIGANO, H
    PAPADATOS, Y
    KELWALA, S
    BAN, TA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 : S385 - S392
  • [46] STIMULANT EFFECTS OF ENERGY DRINK WHEN MIXED WITH ALCOHOL: RESULTS FROM A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Verster, Joris C.
    Van Andel, Nienke
    Van Gelder, Charlotte A. G. H.
    Janssen, Boris S. G.
    Titulaer, Joep
    Jansen, Jimmie
    Van De Loo, Aurora J. A. E.
    DRUG AND ALCOHOL REVIEW, 2015, 34 : 64 - 64
  • [47] Retrospective analysis of Electrocardiographic changes after administration of oral or intravenous garenoxacin in five phase I, placebo-controlled studies in healthy volunteers
    Wang, Zaiqi
    Grasela, Dennis M.
    Krishna, Gopal
    CLINICAL THERAPEUTICS, 2007, 29 (06) : 1098 - 1106
  • [48] Impact of residual symptoms on outcomes in GAD: Evidence from placebo-controlled trials of venlafaxine ER
    Rasmussen, JGC
    Hackett, D
    Meoni, P
    White, C
    EUROPEAN PSYCHIATRY, 2000, 15 : 384S - 384S
  • [49] Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
    Klaiber, Aaron
    Schmid, Yasmin
    Becker, Anna M.
    Straumann, Isabelle
    Erne, Livio
    Jelusic, Alen
    Thomann, Jan
    Luethi, Dino
    Liechti, Matthias E.
    TRANSLATIONAL PSYCHIATRY, 2024, 14 (01):
  • [50] Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects
    Becker, Anna M.
    Holze, Friederike
    Grandinetti, Tanja
    Klaiber, Aaron
    Toedtli, Vanja E.
    Kolaczynska, Karolina E.
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Grunblatt, Edna
    Liechti, Matthias E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (04) : 886 - 895